Publication | Closed Access

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

Urological ResearchUrologyGram-negative UropathogensAntimicrobial StewardshipAntibioticsSepsisUrogynecologyNon-inferiority TrialAntimicrobial ChemotherapyPhase 2MedicineAntimicrobial ResistanceDrug Resistance